Lacerta Therapeutics Revenue
Biotechnology Research • 
Alachua, Florida, United States • 11-20 Employees
Lacerta Therapeutics revenue & valuation
| Annual revenue | $3,500,000 |
| Revenue per employee | $270,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $11,200,000 |
| Total funding | $30,000,000 |
Key Contact at Lacerta Therapeutics
Venu Talla
Director Capsid Engineering
Company overview
| Headquarters | 14189 NW 129th Way, Alachua, Florida 32615, US |
| Phone number | +13865186424 |
| Websites | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Aav Gene Therapy, Aav Capsid Engineering, Aav Capsid Variants, Aav Manufacturing, Cns Disease, Lysosomal Storage Disease |
| Founded | 2017 |
| Employees | 11-20 |
| Socials |
Lacerta Therapeutics Email Formats
Lacerta Therapeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@lacertatx.com), used 71.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@lacertatx.com | 71.4% |
{first name}{last name} | johndoe@lacertatx.com | 28.6% |
About Lacerta Therapeutics
Clinical stage gene therapy company using a constellation of proprietary AAV vector technologies to develop novel treatments for central nervous system and lysosomal storage diseases
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Lacerta Therapeutics has 3 employees across 2 departments.
Departments
Number of employees
Lacerta Therapeutics Tech Stack
Discover the technologies and tools that power Lacerta Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Hosting
Security
Web servers
United Kingdom
Canada
Spain
AustraliaFrequently asked questions
4.8
40,000 users
